STZ

Constellation Brands, Inc.

NYSE • USD • CONSUMER DEFENSIVE • BEVERAGES - WINERIES & DISTILLERIES

Current Price $148.14 5 Years: -38.28%

52-Week Range

$126.45 $196.91

Current price is 30.8% of 52-week range

Key Metrics

Market Cap $25.9B
P/E Ratio N/A
Current Ratio N/A
EPS
Dividend Yield N/A
ATR(14) $4.57
Beta 0.4
PEG Ratio N/A
ROE N/A
Operating Earnings Growth Rate -12.01%

AI Overview

Last updated about 1 month ago

Constellation Brands’ core investment case still rests on the durability of its high-end Mexican beer portfolio (led by Modelo and Corona) and the distribution scale that keeps those brands top-of-mind across U.S. retail and on-premise channels. That said, recent operating data shows the beer franchise is not immune to a softer consumer and tougher comparisons: in fiscal Q3 2026 (reported January 7, 2026), beer depletions fell 3.0%, with declines in Modelo Especial (about 4%) and Corona Extra (nearly 9%) partly offset by strong growth from Pacifico (15%+) and Victoria (13%+). At the same time, management continues to lean into “beyond beer” adjacency via non-alcoholic innovation (e.g., recent launches like Corona Non-Alcoholic and a non-alcoholic Modelo Chelada variant) and M&A/brand-building efforts, which can strengthen relevance as moderation trends persist, but also adds execution risk and potential distraction versus protecting beer share.

Financially, the latest quarter underscores why investors often underwrite STZ as a cash-flowing beer business with a smaller, more volatile wine/spirits exposure. In fiscal Q3 2026, net sales were $2.223B and comparable operating income was $739M, while reported EPS was $2.88 and comparable EPS was $3.06; the company also generated year-to-date operating cash flow of $2.1B and free cash flow of $1.45B. Management reaffirmed fiscal 2026 comparable EPS guidance of $11.30–$11.60 and updated reported EPS guidance to $9.72–$10.02, consistent with meaningful “below-the-line” items weighing GAAP. On valuation, public data around late March 2026 implies a low-to-mid 20s P/E (commonly cited around ~23x) and a market cap in the mid-$20B range, while the dividend is $4.08 annually (roughly a mid‑2% yield depending on price); taken together, STZ does not screen as “cheap,” but it can be reasonable if investors believe beer margins and cash generation remain resilient even with modest volume pressure.

Over the next 12 months (from March 28, 2026), the biggest near-term catalyst is the fiscal Q4 and full-year fiscal 2026 earnings event: the company has already announced it will report on April 8, 2026 after market close and host a call on April 9, 2026, so guidance around fiscal 2027 beer demand, pricing, and input-cost/margin trajectory is likely to drive the stock more than the quarter itself. A second catalyst is evidence that the beer portfolio can re-accelerate as innovations and brand mix (Pacifico/Victoria strength) offset softness in the largest SKUs; if depletions stabilize and management sustains capital returns (dividend plus buybacks, with $220M repurchased in Q3 alone), sentiment can improve quickly. The key risks are (1) continued volume declines in flagship brands that pricing cannot fully offset, compressing operating leverage, and (2) ongoing volatility/structural pressure in wine & spirits (including portfolio reshaping), which can keep reported earnings noisy and reduce investor confidence in consolidated quality.

Recommendation: HOLD. The beer franchise and cash-flow profile remain attractive and the company is actively managing the portfolio while returning capital to shareholders, but the recent depletion softness in key brands and the still-elevated valuation multiple for a business facing near-term volume/mix uncertainty make the risk/reward look more balanced until the April 8, 2026 update clarifies fiscal 2027 demand and margin durability.

Price & Profitability History

5 Years change: -38.28% (-$91.86)

Log in